-
1
-
-
33644618433
-
The biology of incretin hormones
-
Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3: 153-165
-
(2006)
Cell Metab
, vol.3
, pp. 153-165
-
-
Drucker, D.J.1
-
2
-
-
84919685379
-
Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion
-
Gheni G, Ogura M, Iwasaki M, et al. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Reports 2014;9: 661-673
-
(2014)
Cell Reports
, vol.9
, pp. 661-673
-
-
Gheni, G.1
Ogura, M.2
Iwasaki, M.3
-
3
-
-
33846006173
-
The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
-
Drucker DJ, Nauck MA. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368: 1696-1705
-
(2006)
Lancet
, vol.368
, pp. 1696-1705
-
-
Drucker, D.J.1
Nauck, M.A.2
-
4
-
-
0030792753
-
Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells
-
Renström E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 1997;502: 105-118
-
(1997)
J Physiol
, vol.502
, pp. 105-118
-
-
Renström, E.1
Eliasson, L.2
Rorsman, P.3
-
5
-
-
0033769693
-
CAMP-GEFII is a direct target of cAMP in regulated exocytosis
-
Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2000;2: 805-811
-
(2000)
Nat Cell Biol
, vol.2
, pp. 805-811
-
-
Ozaki, N.1
Shibasaki, T.2
Kashima, Y.3
-
6
-
-
0035824548
-
Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion
-
Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 2001;276: 46046-46053
-
(2001)
J Biol Chem
, vol.276
, pp. 46046-46053
-
-
Kashima, Y.1
Miki, T.2
Shibasaki, T.3
-
7
-
-
64549105338
-
Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function
-
Niimura M, Miki T, Shibasaki T, Fujimoto W, Iwanaga T, Seino S. Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol 2009;219: 652-658
-
(2009)
J Cell Physiol
, vol.219
, pp. 652-658
-
-
Niimura, M.1
Miki, T.2
Shibasaki, T.3
Fujimoto, W.4
Iwanaga, T.5
Seino, S.6
-
8
-
-
0034759763
-
Characterization of the gene EPAC2: Structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform
-
Ueno H, Shibasaki T, Iwanaga T, et al. Characterization of the gene EPAC2: Structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform. Genomics 2001;78: 91-98
-
(2001)
Genomics
, vol.78
, pp. 91-98
-
-
Ueno, H.1
Shibasaki, T.2
Iwanaga, T.3
-
9
-
-
37649002935
-
Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP
-
Shibasaki T, Takahashi H, Miki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci U S A 2007;104: 19333-19338
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 19333-19338
-
-
Shibasaki, T.1
Takahashi, H.2
Miki, T.3
-
11
-
-
79957900616
-
Dynamics of insulin secretion and the clinical implications for obesity and diabetes
-
Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 2011;121: 2118-2125
-
(2011)
J Clin Invest
, vol.121
, pp. 2118-2125
-
-
Seino, S.1
Shibasaki, T.2
Minami, K.3
-
12
-
-
0033037098
-
ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies
-
Seino S. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999;61: 337-362
-
(1999)
Annu Rev Physiol
, vol.61
, pp. 337-362
-
-
Seino, S.1
-
13
-
-
0033760442
-
Triggering and amplifying pathways of regulation of insulin secretion by glucose
-
Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000;49: 1751-1760
-
(2000)
Diabetes
, vol.49
, pp. 1751-1760
-
-
Henquin, J.C.1
-
14
-
-
84886590372
-
K(ATP) Channels and islet hormone secretion: New insights and controversies
-
Ashcroft FM, Rorsman P. K(ATP) channels and islet hormone secretion: New insights and controversies. Nat Rev Endocrinol 2013;9: 660-669
-
(2013)
Nat Rev Endocrinol
, vol.9
, pp. 660-669
-
-
Ashcroft, F.M.1
Rorsman, P.2
-
15
-
-
68149136367
-
The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs
-
Zhang CL, Katoh M, Shibasaki T, et al. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 2009;325: 607-610
-
(2009)
Science
, vol.325
, pp. 607-610
-
-
Zhang, C.L.1
Katoh, M.2
Shibasaki, T.3
-
16
-
-
84886737102
-
Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A
-
Takahashi T, Shibasaki T, Takahashi H, et al. Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A. Sci Signal 2013;6: Ra94
-
(2013)
Sci Signal
, vol.6
, pp. ra94
-
-
Takahashi, T.1
Shibasaki, T.2
Takahashi, H.3
-
17
-
-
62449129181
-
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
-
LEAD-1 SU study group
-
Marre M, Shaw J, Brändle M, et al.; LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med 2009;26: 268-278
-
(2009)
Diabet Med
, vol.26
, pp. 268-278
-
-
Marre, M.1
Shaw, J.2
Brändle, M.3
-
18
-
-
84871651233
-
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
-
Kubota A, Maeda H, Kanamori A, et al. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients. J Diabetes Investig 2012;3: 503-509
-
(2012)
J Diabetes Investig
, vol.3
, pp. 503-509
-
-
Kubota, A.1
Maeda, H.2
Kanamori, A.3
-
19
-
-
84908569527
-
Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
-
Yabe D, Seino Y. Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe? J Diabetes Investig 2014;5: 475-477
-
(2014)
J Diabetes Investig
, vol.5
, pp. 475-477
-
-
Yabe, D.1
Seino, Y.2
-
20
-
-
0029799525
-
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas
-
Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996;19: 857-863
-
(1996)
Diabetes Care
, vol.19
, pp. 857-863
-
-
Gutniak, M.K.1
Juntti-Berggren, L.2
Hellström, P.M.3
Guenifi, A.4
Holst, J.J.5
Efendic, S.6
-
21
-
-
59749096702
-
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
-
Aaboe K, Knop FK, Vilsboll T, et al. KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. J Clin Endocrinol Metab 2009;94: 603-608
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 603-608
-
-
Aaboe, K.1
Knop, F.K.2
Vilsboll, T.3
-
22
-
-
15944419821
-
Distinct effects of glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility
-
Miki T, Minami K, Shinozaki H, et al. Distinct effects of glucosedependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 2005;54: 1056-1063
-
(2005)
Diabetes
, vol.54
, pp. 1056-1063
-
-
Miki, T.1
Minami, K.2
Shinozaki, H.3
-
23
-
-
79953757245
-
Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/ cyclic adenosine monophosphate signaling
-
Iwasaki M, Minami K, Shibasaki T, Miki T, Miyazaki J, Seino S. Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/ cyclic adenosine monophosphate signaling. J Diabetes Investig 2010;1: 137-142
-
(2010)
J Diabetes Investig
, vol.1
, pp. 137-142
-
-
Iwasaki, M.1
Minami, K.2
Shibasaki, T.3
Miki, T.4
Miyazaki, J.5
Seino, S.6
-
24
-
-
31844447089
-
Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state
-
Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 2006;439: 625-628
-
(2006)
Nature
, vol.439
, pp. 625-628
-
-
Rehmann, H.1
Das, J.2
Knipscheer, P.3
Wittinghofer, A.4
Bos, J.L.5
-
25
-
-
51349150613
-
Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B
-
Rehmann H, Arias-Palomo E, Hadders MA, Schwede F, Llorca O, Bos JL. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 2008;455: 124-127
-
(2008)
Nature
, vol.455
, pp. 124-127
-
-
Rehmann, H.1
Arias-Palomo, E.2
Hadders, M.A.3
Schwede, F.4
Llorca, O.5
Bos, J.L.6
-
26
-
-
79955961854
-
Mechanism of intracellular cAMP sensor Epac2 activation: CAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS)
-
Li S, Tsalkova T, White MA, et al. Mechanism of intracellular cAMP sensor Epac2 activation: CAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Biol Chem 2011;286: 17889-17897
-
(2011)
J Biol Chem
, vol.286
, pp. 17889-17897
-
-
Li, S.1
Tsalkova, T.2
White, M.A.3
-
28
-
-
84891698714
-
Pancreatic β-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A
-
Song WJ, Mondal P, Li Y, Lee SE, Hussain MA. Pancreatic β-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A. Diabetes 2013;62: 2796-2807
-
(2013)
Diabetes
, vol.62
, pp. 2796-2807
-
-
Song, W.J.1
Mondal, P.2
Li, Y.3
Lee, S.E.4
Hussain, M.A.5
-
29
-
-
0034617282
-
Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs
-
de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 2000;275: 20829-20836
-
(2000)
J Biol Chem
, vol.275
, pp. 20829-20836
-
-
De Rooij, J.1
Rehmann, H.2
Van Triest, M.3
Cool, R.H.4
Wittinghofer, A.5
Bos, J.L.6
-
30
-
-
0032545328
-
A family of cAMP-binding proteins that directly activate Rap1
-
Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998;282: 2275-2279
-
(1998)
Science
, vol.282
, pp. 2275-2279
-
-
Kawasaki, H.1
Springett, G.M.2
Mochizuki, N.3
-
31
-
-
77949538387
-
Epac: Defining a new mechanism for cAMP action
-
Gloerich M, Bos JL. Epac: Defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 2010;50: 355-375
-
(2010)
Annu Rev Pharmacol Toxicol
, vol.50
, pp. 355-375
-
-
Gloerich, M.1
Bos, J.L.2
-
32
-
-
78650090455
-
2+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-e knockout mice
-
2+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-e knockout mice. J Physiol 2010;588: 4871-4889
-
(2010)
J Physiol
, vol.588
, pp. 4871-4889
-
-
Dzhura, I.1
Chepurny, O.G.2
Kelley, G.G.3
-
33
-
-
79955793555
-
Phospholipase C-e links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans
-
Dzhura I, Chepurny OG, Leech CA, et al. Phospholipase C-e links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans. Islets 2011;3: 121-128
-
(2011)
Islets
, vol.3
, pp. 121-128
-
-
Dzhura, I.1
Chepurny, O.G.2
Leech, C.A.3
-
34
-
-
77953466435
-
Facilitation of β-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
-
Leech CA, Dzhura I, Chepurny OG, Schwede F, Genieser HG, Holz GG. Facilitation of β-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac. Islets 2010;2: 72-81
-
(2010)
Islets
, vol.2
, pp. 72-81
-
-
Leech, C.A.1
Dzhura, I.2
Chepurny, O.G.3
Schwede, F.4
Genieser, H.G.5
Holz, G.G.6
-
37
-
-
84907044034
-
2+ in female mouse islets stimulated by glucose and tolbutamide
-
2+ in female mouse islets stimulated by glucose and tolbutamide. Endocrinology 2014;155: 3274-3287
-
(2014)
Endocrinology
, vol.155
, pp. 3274-3287
-
-
Henquin, J.C.1
Nenquin, M.2
-
39
-
-
79957904659
-
Rim2a determines docking and priming states in insulin granule exocytosis
-
Yasuda T, Shibasaki T, Minami K, et al. Rim2a determines docking and priming states in insulin granule exocytosis. Cell Metab 2010;12: 117-129
-
(2010)
Cell Metab
, vol.12
, pp. 117-129
-
-
Yasuda, T.1
Shibasaki, T.2
Minami, K.3
|